Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bullish On Bristol-Myers
Seeking Alpha
Wednesday, April 29, 2009 - 10:10am
tags:
Bristol-Myers Squibb, Exelixis, ZymoGenetics
Personalized Medicine: The Next Big Thing
Seeking Alpha
Wednesday, April 29, 2009 - 10:03am
tags:
personalized medicine
Isis and Alnylam Form New Collaboration to Develop Single-Stranded RNAi Technology
Yahoo
Wednesday, April 29, 2009 - 9:11am
tags:
Isis Pharmaceuticals, Alnylam, RNAi, partnerships
Peregrine reports positive data from second Phase II breast cancer trial
Pharmaceutical Business Review
Wednesday, April 29, 2009 - 8:58am
tags:
Peregrine Pharmaceuticals, data trials, breast cancer
Wyeth wins European approval for osteoporosis drug
Pharmaceutical Business Review
Wednesday, April 29, 2009 - 8:57am
tags:
Wyeth, Europe, osteoporosis, CONBRIZA
Endo Pharma 1Q Net Drops 34% On Acquisition Costs
WSJ Online
Wednesday, April 29, 2009 - 8:43am
tags:
Endo, earnings
Supreme Court Denies Aventis' Cert Petition in Lovenox Case
Seeking Alpha
Wednesday, April 29, 2009 - 8:41am
tags:
Sanofi, Supreme Court, Lovenox
United Therapeutics says FDA now plans to rule on inhaled blood pressure drug by July 30
Yahoo/AP
Wednesday, April 29, 2009 - 7:38am
tags:
United Therapeutics, FDA, hypertension, Tyvaso
5 Potential Pandemic Shorts
Seeking Alpha
Wednesday, April 29, 2009 - 7:35am
tags:
Biocryst, Novavax, Crucell, Cerus, Gilead Sciences
Sanofi-Aventis to halt work on 3 Phase III experimental drugs after pipeline review
Yahoo/AP
Wednesday, April 29, 2009 - 7:34am
tags:
Sanofi, pipelines, Saredutant, TroVax, Unifive
Wyeth profit beats forecast, but revenue disappoints
Yahoo/Reuters
Wednesday, April 29, 2009 - 7:34am
tags:
Wyeth, earnings
Sanofi Says Swine-Flu Vaccine May Mean No Seasonal Flu Shot
Bloomberg
Wednesday, April 29, 2009 - 6:08am
tags:
Sanofi, vaccines, swine flu, Flu
Sanofi Profit Climbs 16%, Helped by Lantus
Bloomberg
Wednesday, April 29, 2009 - 6:07am
tags:
Sanofi, Lantus, earnings
Dendreon's Provenge Passes the Test
TheStreet.com
Tuesday, April 28, 2009 - 5:44pm
tags:
Provenge, FDA, Dendreon, prostate cancer
Micromet: Drug Development Update
Seeking Alpha
Tuesday, April 28, 2009 - 4:11pm
tags:
Micromet, pipelines
Following patient death, Cephalon warns of using Treanda with allopurinol
Bizjournals.com
Tuesday, April 28, 2009 - 4:10pm
tags:
Cephalon, Treanda, allopurinol, cancer
Bristol-Myers, Pfizer slip; Dendreon to post test data
Marketwatch
Tuesday, April 28, 2009 - 4:08pm
tags:
Pfizer, Dendreon, Bristol-Myers Squibb, earnings, Provenge, prostate cancer
The Costs of Being Pfizer
Motley Fool
Tuesday, April 28, 2009 - 4:07pm
tags:
Pfizer, earnings, Wyeth
They're hiring! Abbott Laboratories
Fortune
Tuesday, April 28, 2009 - 10:47am
tags:
Abbott Laboratories
Medical experts want crackdown on drugmaker money
Yahoo/AP
Tuesday, April 28, 2009 - 10:14am
tags:
physician payments

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.